|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phaes U study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer 显示文摘 | Bajetta E Celio L Buzzoni R | 2003 | Ann Oncol2003，14，10： | 1 |
| 2 | Ovarian ablation for premenopausal early-stage breast cancer:an update显示文摘 | Celio L Bajetta E Toffolatti L | 2000 | Tumori2000，86，3： | 1 |
| 3 | Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced bymoderately emetogenic chemotherapy显示文摘 | Celio L Agustoni F Testa I | 2012 | Tumori2012，98，3： | 1 |
| 4 | Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients显示文摘 | Cappelletti V Celio L Bajetta E | 2004 | Endocr Relat Cancer2004，11，4： | 1 |
| 5 | Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer:a multi-institutional phase Ⅱ study显示文摘 | Celio L Sternberg CN Labianca R | 2009 | Annals of Oncology2009，20，： | 1 |
| 6 | Safety and efficacy of twodifferent doses of capecitabine in the treatment of advanced breastcancer in older women显示文摘 | BajettaE Procopio G Celio L | 2005 | J Clin Oncol2005，23，10： | 1 |
| 7 | Phase I , pharmacokinetic, and DCE-MRI correlative study of AVE8062A, an antivascular combretastatin analogue, administered weekly for 3 weeks every 28 days 显示文摘 | TOLCHER A W FORERO L CELIO P | 2003 | Proc Am Soc Clin Oncol2003，22，9： | 1 |
| 8 | Multiple isola- tions of a eulturable, motile Ichthyosporean (Mesomyeetozoa, Opisthokonta), Creolimax fragrantissima n gen, n sp, from ma- rine invertebrate digestive tracts 显示文摘 | Marshall W L Celio G MeLaughlin D J | 2008 | Protist2008，159，3： | 1 |
| 9 | Pemetrexed in combi- nation with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phaseⅡ study显示文摘 | Celio L Sternberg CN Labianca R | 2009 | Annals of Oncolo- gy2009，20，： | 1 |
| 10 | Pemetrexed in gastric cancer: clinical experience and future perspectives显示文摘 | Celio L Buzzoni R Longarini R | 2002 | Semin On- col2002，29，618： | 1 |
| 11 | Palonosetron plus dexamethasone in highly emetogenic chemotherapy:pooled data from two PhaseⅢtrials显示文摘 | Celio L Agustoni F Ricchini F | 2013 | Future Oncol2013，9，10： | 1 |
| 12 | Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women显示文摘 | Bajetta E Procopio G Celio L | 2005 | J Clin Oncol2005，23，10： | 1 |
| 13 | Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance 显示文摘 | Bleecker M L Ford D P Celio M A | 2007 | Neurology2007，69，5： | 1 |
| 14 | Phase Ⅱ study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer 显示文摘 | Bajetta E Celio L Buzzoni R | 2003 | Ann Oncol2003，14，10： | 1 |
| 15 | Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer:a multi-institutional phase Ⅱ study显示文摘 | CELIO L STERNBERG CN LABIANCA R | 2009 | Ann Oncol2009，20，6： | 1 |
| 16 | Multicenter phase Ⅱ study of pemetrexed and oxaliplatin as first-line therapy in advanced gastric cancer 显示文摘 | Celio L | 2006 | J Clin Oncol2006，24，18： | 1 |
| 17 | Phase I , pharmacokinetic, and DCE-MRI correlative study of AVES062A, an antivascular combretastatin analogue, administered weekly for 3 weeks every 28 days 显示文摘 | Tolcher AW Forero L Celio P | 2003 | J Clin Oncol2003，，： | 1 |
| 18 | Phase Ⅱ study of pemetrexed disodium (Alimta) administered with oral folie acid in patients with advanced gastric cancer显示文摘 | Bajetta E Celio L Buzzoni R | 2003 | Ann Oncol2003，14，10： | 1 |
| 19 | Muhicenter phase II study of pemetrexed and oxaliplatin as fist-line therapy in advanced gastric cancer显示文摘 | Celio L | 2006 | Journal of Clinical Oncology 2006 ASCO Annual Meeting Proceedings ( Post-Meeting Edition )2006，24，14： | 1 |
| 20 | Multicenter phase Ⅱ study of pemetrexed and oxaliplatin as first line therapy in advanced gastric cancer显示文摘 | Celio L | 2006 | Journal of Clinical Oncology2006，24，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员